These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 23269)
1. N-Acetylation of drugs. A genetically controlled reciprocal relationship between drug N-acetylating enzymes of rabbit liver and peripheral blood cells. Szabadi RR; McQueen CA; Drummond GS; Weber WW Drug Metab Dispos; 1978; 6(1):16-20. PubMed ID: 23269 [TBL] [Abstract][Full Text] [Related]
2. N-acetylation pharmacogenetics. Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivo. Andres HH; Weber WW Drug Metab Dispos; 1986; 14(4):382-5. PubMed ID: 2873982 [TBL] [Abstract][Full Text] [Related]
3. N-acetylation of drugs. Pharmacogenetic studies in rabbits selected for their acetylator characteristics. Weber WW; Miceli JN; Hearse DJ; Drummond GS Drug Metab Dispos; 1976; 4(1):94-101. PubMed ID: 3408 [TBL] [Abstract][Full Text] [Related]
4. Immunological evidence for N-acetyltransferase isozymes in the rabbit. Reeves PT; Kinnear BF; Minchin RF; Ilett KF Mol Pharmacol; 1991 Jan; 39(1):42-8. PubMed ID: 1987451 [TBL] [Abstract][Full Text] [Related]
5. Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens among established inbred rabbit strains. Hein DW; Smolen TN; Fox RR; Weber WW J Pharmacol Exp Ther; 1982 Oct; 223(1):40-4. PubMed ID: 7120125 [TBL] [Abstract][Full Text] [Related]
11. Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver. Grant DM; Mörike K; Eichelbaum M; Meyer UA J Clin Invest; 1990 Mar; 85(3):968-72. PubMed ID: 2312737 [TBL] [Abstract][Full Text] [Related]
12. Biochemical evidence for the coexistence of monomorphic and polymorphic N-acetyltransferase activities on a common protein in rabbit liver. Hein DW; Hirata M; Glowinski IB; Weber WW J Pharmacol Exp Ther; 1982 Jan; 220(1):1-7. PubMed ID: 7053406 [TBL] [Abstract][Full Text] [Related]
13. A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster. Hein DW; Omichinski JG; Brewer JA; Weber WW J Pharmacol Exp Ther; 1982 Jan; 220(1):8-15. PubMed ID: 7053425 [TBL] [Abstract][Full Text] [Related]
14. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Grant DM; Blum M; Beer M; Meyer UA Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083 [TBL] [Abstract][Full Text] [Related]
15. Inheritance of liver N-acetyltransferase activity in the rapid and slow acetylator inbred hamster. Hein DW; Kirlin WG; Ferguson RJ; Weber WW J Pharmacol Exp Ther; 1985 Jun; 233(3):584-7. PubMed ID: 3874278 [TBL] [Abstract][Full Text] [Related]
16. Ecogenetic studies of drug acetylation in man and rats. Dubbels R; Khoory R; Schloot W Acta Anthropogenet; 1981; 5(2):111-8. PubMed ID: 7271997 [TBL] [Abstract][Full Text] [Related]
17. An enzyme marker to ensure reliable determinations of human isoniazid acetylator phenotype in vitro. Hein DW; Hirata M; Weber WW Pharmacology; 1981; 23(4):203-10. PubMed ID: 6976581 [TBL] [Abstract][Full Text] [Related]
18. Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferase. Hearse DJ; Weber WW Biochem J; 1973 Mar; 132(3):519-26. PubMed ID: 4724587 [TBL] [Abstract][Full Text] [Related]
19. Extrahepatic expression of N-acetylator genotype in the inbred hamster. Hein DW; Kirlin WG; Ogolla F; Trinidad A Drug Metab Dispos; 1987; 15(1):68-73. PubMed ID: 2881761 [TBL] [Abstract][Full Text] [Related]
20. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells. Frederickson SM; Messing EM; Reznikoff CA; Swaminathan S Cancer Epidemiol Biomarkers Prev; 1994; 3(1):25-32. PubMed ID: 8118381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]